Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI chatbot aims to ease postpartum loneliness and boost pelvic floor health

NCT ID NCT07223736

Symptom relief Sponsor: University of California, San Diego Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 06, 2026 · Updated 3 times

Summary

This study tests whether a generative AI chatbot can help new mothers learn about pelvic floor health and reduce feelings of loneliness after childbirth. Researchers will compare standard postpartum care with or without access to the chatbot over 4 weeks. The trial involves 130 first-time mothers who are 2-6 weeks postpartum.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
generative AI chatbot
What this could lead to
If it works, this could offer new mothers a simple, accessible way to get reliable postpartum health information and feel less isolated.
What could go wrong
This is a small, early-stage trial with only 130 participants. The chatbot may not improve knowledge or loneliness more than standard care, and results may not apply to all mothers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 130 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Has the capacity to provide informed consent 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. Postpartum persons, aged \>18 years old 4. Primiparous 5. Vaginal or cesarean delivery 6. English Speaking 7. Internet access and proficiency of internet access 8. Access to a smartphone 9. Postpartum 2-6 weeks Exclusion Criteria: 1. Multiparous 2. Major neonatal anomaly 3. Delivery \< 34 weeks gestational age 4. Intrauterine fetal demise (IUFD) 5. Enrollment in any interfering studies 6. Unanticipated NICU admission 7. Discharge home without live baby 8. Surrogates/gestational carrier 9. Birthing individuals with baby placed for adoption 10. Currently pregnant 11. Psychiatric history requiring psychiatric hospitalization prior to delivery 12. Other psychiatric conditions needing immediate attention and intervention as determined by study team and/or treatment team

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Artificial intelligence (AI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression depressive disorder mental disorder Pelvic Floor Disorders Psychological Well-Being puerperal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Artificial intelligence (AI) Chatbot Depression Loneliness Mental health Pelvic floor disorder Peritraumatic distress Postpartum Women

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of California San Diego

    RECRUITING

    La Jolla, California, 92093, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.